Réunion du 29 Mars 2022 à Paris (Faculté de Villemin)
8:00: Welcome to the Nine-i.
8:30: Who’s who at the 6th Nine-i meeting
CHAIR: Victoria Metaxa, Jordi Rello
8:45: Is it relevant to monitor respiratory comfort in immunocompromised patients? Alexandre Demoule, Paris
9:15: A new AI-look on the HIGH data. Dominic Marshall, Matthieu Komorowski, London
9:45: ECMO for cancer patients. Yes: Matthias Kochanek, Cologne. No: Peter Schellongowski, Vienna
10:15: The Efraim 3 study: 10,000 patients to address five clinical questions. Elie Azoulay, Paris
10:45: Coffee break
CHAIR: Lene Russel, Anne-Sophie Moreau
11:15: The Nine-i: Learning from our variability. Michael Darmon, Paris
11:45: A statement on TPE in the ICU. Philippe Bauer, Rochester. Marlies Ostermann, London
12:15: Management of Veno-occlusive disease (VOD/SOS). Santhosh Thyagu, Toronto
12:45: COVID-19 has been a proof of concept for RCTs. Anders Perner, Copenhaguen
1:15: Lunch break Bon Appétit
CHAIR: Nadia Aissaoui, Andry Van de Louw
2:30: Mech. ventilation benefits to lung cancer patients. PRO: Naike Bigé, Villejuif, CON: Pedro Castro, Barcelona
3:00: Tell me who you admit to the ICU and I’ll tell you who you are. Emmanuel Canet, Nantes
3:30: CAR T 2022: New challenges, new chances. Michael Von Bergwelt, Munich
4:00: Alarmins, a whistleblower for tumor lysis syndrome. Lara Zafrani, Paris
4:30: Hepatic dysfunction in critically ill cancer patients. Djamel Mokart, Marseille
5:00: The backlash from sepsis in cancer. Frédéric Pène, Paris
